Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

Receive Latest News

Feedburner
Share Us

FDA Scrutiny of Promotion and Advertising Practices

View: 81

Website http://bit.ly/2he4Fww | Edit Freely

Category FDA Compliance;

Deadline: January 24, 2017 | Date: January 24, 2017-January 25, 2017

Venue/Country: Burlingame, U.S.A

Updated: 2017-01-04 19:39:53 (GMT+9)

Call For Papers - CFP

If you go "off label" with advertising and promotion, you become embroiled in FDA's advertising and promotion requirements. For devices, the law is weak and lacks legal clarity. For drugs, the regulations are prescriptive and guidance documents clamp down on nuances. Marketing and regulatory affairs departments need to collaborate now more than ever before. Firms need to identify practical criteria to make marketing decisions. The big question is whether or not marketing managers and regulatory affairs managers will really try to reach common ground. FDA's Center for Devices and Radiological Health (CDRH) has never issued a comprehensive guidance on advertising and promotion. You are on your own. FDA's Center for Drug Evaluation and Research (CDER) uses long-standing regulations and a growing number of guidance documents in its regulatory approach. Policing social media has become a new regulatory responsibility. Bottom line, do you know when you are running afoul of FDA's requirements or are you guessing? Can you afford to guess? The cost to your business and the confusion left in your customer's mind becomes an unwelcomed nightmare.

With this seminar you will learn how to navigate FDA's numerous legal options and how to interpret them based on basic legal principles. Applying new guidance documents becomes a new test of the FDA's legal boundaries and enforcement options. The agency now applies the principles of cognitive psychology to aid in its determination of what a message really conveys. This academic discipline may or may not get to the root of what consumers take away as the message. What is more challenging is whether a consumer's mind makes its decisions on what it learns versus pre-existing emotional factors that may or may not be conscious.

Learning Objective:

Learn how FDA faces constitutional constraints on enforcement decisions

Learn about intersecting federal requirements by the Department of Justice, the Federal Trade Commission, the Securities and Exchange Commission and the Consumer Product Safety Commission

Learn how the FDA interprets advertising and promotion in principle and in fact

Understand ways that a firm violates FDA requirements

Who will Benefit:

Sales and Marketing executives and managers

Regulatory Managers

In-house Legal Counsel and Contract Specialists

3rtd party consultants

Venture Capitalists

Investors

Business Acquisition Executives

Owners of New or Developing Firms

Note:

Use coupon code NB5SQH8N and get 10% off on registration.

For Registration:

http://www.complianceonline.com/fda-scrutiny-promotion-advertising-practices-ftc-mass-media-doj-off-label-seminar-training-80273SEM-prdsm?channel=ourglocal


Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.